Treatment of mice with anti-CD4 by intranasal (i.n.)and intraperitoneal (i.p.)administration of the antibodies from day 7 of infection significantly reduced the numbers of CD4 T cells in the nasal tissue during infection with B. pertussis (Fig. 5a). The gene discussed is CD4; the disease is infection.